Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170,403,883
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
15,203,165
-
Shares change
-
+1,392,010
-
Total reported value, excl. options
-
$533,480,616
-
Value change
-
+$51,097,629
-
Put/Call ratio
-
56.35%
-
Number of buys
-
48
-
Number of sells
-
-17
-
Price
-
$35.09
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q4 2015
76 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q4 2015.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15,203,165 shares
of 170,403,883 outstanding shares and own 8.92% of the company stock.
Largest 10 shareholders include FMR LLC (5,858,365 shares), PRICE T ROWE ASSOCIATES INC /MD/ (961,650 shares), FEDERATED INVESTORS INC /PA/ (694,980 shares), BlackRock Fund Advisors (662,077 shares), Flagship Ventures 2007 General Partner LLC (599,297 shares), WADDELL & REED FINANCIAL INC (585,567 shares), VANGUARD GROUP INC (544,752 shares), TimesSquare Capital Management, LLC (500,000 shares), JENNISON ASSOCIATES LLC (398,959 shares), and BRIDGER MANAGEMENT, LLC (381,300 shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.